Position in DXCM
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$6,092,793
-$346,358 QoQ
Shares Held
97,019
0.0% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Calamos Advisors LLC holds $249,655,686 across 14 Medical Devices names. DXCM ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
602,965 | $52,246,917 | |
| 2 | SYK |
Stryker Corp
|
158,628 | $52,123,574 | |
| 3 | BSX |
Boston Scientific Corp
|
817,686 | $51,309,796 | |
| 4 | ABT |
Abbott Laboratories
|
378,774 | $38,888,726 | |
| 5 | PEN |
Penumbra Inc
|
66,882 | $21,962,042 | |
| 6 | EW |
Edwards Lifesciences Corp
|
166,828 | $13,359,586 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
107,091 | $7,622,737 | |
| 8 | DXCM |
Dexcom Inc
This page
|
97,019 | $6,092,793 |
All Filings in DXCM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,092,793 | 97,019 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $6,439,151 | 97,019 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $6,793,531 | 100,959 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $8,812,711 | 100,959 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $6,894,490 | 100,959 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $13,649,179 | 175,507 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $11,738,435 | 175,096 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $36,953,376 | 325,925 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $39,373,462 | 283,875 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $34,107,749 | 274,863 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $27,131,173 | 290,795 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $37,322,516 | 290,425 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $29,586,282 | 254,659 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $30,446,385 | 268,866 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $11,699,159 | 145,259 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $8,642,796 | 115,964 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $25,967,281 | 50,757 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $23,594,656 | 43,942 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $24,590,106 | 44,966 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $20,705,230 | 48,490 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $17,475,698 | 48,626 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $14,054,536 | 38,014 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $15,675,457 | 38,026 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,036,607 | 2,557 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $256,614 | 953 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||